ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Pharming Group NV

Pharming Group NV (PHAR)

12.28
-0.31
(-2.46%)
終値: 6月11日 5:00AM
12.28
0.00
( 0.00% )
取引時間後: 5:30AM

Pharming Group NV (PHAR) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
12.28
( -2.46% )
買値
11.50
売値
13.00
出来高
3,865
12.465 日の範囲 12.63
9.5354 52 週間の範囲 21.34
時価総額
前日終値
12.59
始値
12.51
最終取引時間
05:52:16
財務取引量
US$ 48,283
VWAP
12.4925
平均取引量 (3 か月)
US$ 12,283,392
発行済株式数
706,252,300
配当利回り
PER
79.1
1 株当たり利益 (EPS)
0.02
歳入
369.49M
純利益
12.36M

Pharming Group NV について

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for th... Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Leiden, Netherlands
設立
1988
Pharming Group NV is listed in the Healthcare sector of the ナスダック市場 with ticker PHAR. The last closing price for Pharming Group NV was US$12.59. Over the last year, Pharming Group NV shares have traded in a share price range of US$ 9.5354 to US$ 21.34.

Pharming Group NV currently has 706,252,300 shares in issue. The market capitalisation of Pharming Group NV is US$8.67 billion. Pharming Group NV has a price to earnings ratio (PE ratio) of 79.10.

PHAR 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.030.24489795918412.2513.211.96816512.55111141DR
4-0.58-4.510108864712.8613.7711.841259212.88344959DR
12-3.29-21.130378933815.5718.4111.83011504714.78137385DR
26-4.87-28.396501457717.1521.3411.83012282216.46371457DR
520.393.2800672834311.8921.349.53541752215.73383473DR
1560.211.7398508699312.0721.346.65886013.60482375DR
2600.181.4876033057912.121.346.1826312.80908344DR

PHAR - Frequently Asked Questions (FAQ)

What is the current Pharming Group NV share price?
The current share price of Pharming Group NV is US$ 12.28
How many Pharming Group NV shares are in issue?
Pharming Group NV has 706,252,300 shares in issue
What is the market cap of Pharming Group NV?
The market capitalisation of Pharming Group NV is USD 8.67B
What is the 1 year trading range for Pharming Group NV share price?
Pharming Group NV has traded in the range of US$ 9.5354 to US$ 21.34 during the past year
What is the PE ratio of Pharming Group NV?
The price to earnings ratio of Pharming Group NV is 79.1
What is the cash to sales ratio of Pharming Group NV?
The cash to sales ratio of Pharming Group NV is 2.47
What is the registered address of Pharming Group NV?
The registered address for Pharming Group NV is Darwinweg 24, Leiden, Zuid-Holland, 2333 CR
What is the Pharming Group NV website address?
The website address for Pharming Group NV is www.pharming.com
Which industry sector does Pharming Group NV operate in?
Pharming Group NV operates in the Biotechnology & Life Sciences sector

PHAR 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock